Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer

PURPOSE: Jab1 is a coactivator of c-Jun that enhances the transcriptional function of c-Jun. Jab1 is frequently overexpressed in various cancers and is associatedwith poor prognosis of cancer patients. Thus, Jab1 could be a potential therapeutic target in cancer. However, the role of Jab1 in biliary...

Descripción completa

Detalles Bibliográficos
Autores principales: Nam, Ah-Rong, Kim, Ji-Won, Park, Ji Eun, Bang, Ju-Hee, Jin, Mei Hua, Oh, Do-Youn, Bang, Yung-Jue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639236/
https://www.ncbi.nlm.nih.gov/pubmed/30282449
http://dx.doi.org/10.4143/crt.2018.375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639236/
https://www.ncbi.nlm.nih.gov/pubmed/30282449
http://dx.doi.org/10.4143/crt.2018.375

Ejemplares similares